These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 28426850)

  • 21. Risk Assessment of Secondary Primary Malignancies in Nasopharyngeal Carcinoma: A Big-Data Intelligence Platform-Based Analysis of 6,377 Long-term Survivors from an Endemic Area Treated with Intensity-Modulated Radiation Therapy during 2003-2013.
    Zhang LL; Li GH; Li YY; Qi ZY; Lin AH; Sun Y
    Cancer Res Treat; 2019 Jul; 51(3):982-991. PubMed ID: 30309219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conditional relative survival among long-term survivors of adolescent and young adult cancers.
    Anderson C; Smitherman AB; Nichols HB
    Cancer; 2018 Jul; 124(14):3037-3043. PubMed ID: 29742278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort.
    Gibson TM; Mostoufi-Moab S; Stratton KL; Leisenring WM; Barnea D; Chow EJ; Donaldson SS; Howell RM; Hudson MM; Mahajan A; Nathan PC; Ness KK; Sklar CA; Tonorezos ES; Weldon CB; Wells EM; Yasui Y; Armstrong GT; Robison LL; Oeffinger KC
    Lancet Oncol; 2018 Dec; 19(12):1590-1601. PubMed ID: 30416076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
    Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
    Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in the risk and burden of second primary malignancy among survivors of smoking-related cancers in the United States.
    Adjei Boakye E; Buchanan P; Hinyard L; Osazuwa-Peters N; Simpson MC; Schootman M; Piccirillo JF
    Int J Cancer; 2019 Jul; 145(1):143-153. PubMed ID: 30613963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008.
    Donin N; Filson C; Drakaki A; Tan HJ; Castillo A; Kwan L; Litwin M; Chamie K
    Cancer; 2016 Oct; 122(19):3075-86. PubMed ID: 27377470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival difference between secondary and de novo acute myeloid leukemia by age, antecedent cancer types, and chemotherapy receipt.
    Sedeta E; Jemal A; Nisotel L; Sung H
    Cancer; 2024 Jun; 130(11):1952-1963. PubMed ID: 38244208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of second primary malignancy in patients with non-Hodgkin lymphoma: a nationwide population-based study.
    Chien SH; Liu CJ; Hong YC; Teng CJ; Hu YW; Ku FC; Yeh CM; Chiou TJ; Gau JP; Tzeng CH
    J Cancer Res Clin Oncol; 2015 Nov; 141(11):1995-2004. PubMed ID: 25971624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic medical conditions and late effects following non-Hodgkin lymphoma in HIV-uninfected and HIV-infected adolescents and young adults: a population-based study.
    Abrahão R; Li QW; Malogolowkin MH; Alvarez EM; Ribeiro RC; Wun T; Keegan THM
    Br J Haematol; 2020 Aug; 190(3):371-384. PubMed ID: 32080836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased risk of second primary malignancy in pediatric and young adult patients treated with radioactive iodine for differentiated thyroid cancer.
    Marti JL; Jain KS; Morris LG
    Thyroid; 2015 Jun; 25(6):681-7. PubMed ID: 25851829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risks for noncutaneous second primary malignancy in cutaneous malignant melanoma survivors: an analysis of data from the Surveillance, Epidemiology, and End Results (SEER) program.
    Vakharia PP; Kelm RC; Orrell KA; Patel KR; Singam V; Ali Y; Rastogi S; Yousif R; Rangel SM; West DP; Nardone B
    Int J Dermatol; 2020 Apr; 59(4):463-468. PubMed ID: 31971260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do survivors of borderline ovarian tumors have susceptibility to secondary primary malignancies? A SEER population-based study.
    Wang J; Du Y; Kang Y
    Int J Gynaecol Obstet; 2024 Jun; 165(3):1229-1236. PubMed ID: 38205842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival Trends Among Adolescents and Young Adults Diagnosed With Cancer in the United States: Comparisons With Children and Older Adults.
    Keegan THM; Abrahão R; Alvarez EM
    J Clin Oncol; 2024 Feb; 42(6):630-641. PubMed ID: 37883740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring the risk of second primary malignancies in laryngeal cancer survivors: insights from the SEER database.
    Afify AY; Ashry MH
    Eur Arch Otorhinolaryngol; 2024 Aug; 281(8):4409-4417. PubMed ID: 38775833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second primary head and neck cancer after Hodgkin lymphoma: a population-based study of 44,879 survivors of Hodgkin lymphoma.
    Chowdhry AK; McHugh C; Fung C; Dhakal S; Constine LS; Milano MT
    Cancer; 2015 May; 121(9):1436-45. PubMed ID: 25572913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second primary malignancy in diffuse large B-cell lymphoma patients: A SEER database analysis.
    Jiang S; Zhen H; Jiang H
    Curr Probl Cancer; 2020 Feb; 44(1):100502. PubMed ID: 31537411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Second Primary Malignancies in Patients with Colorectal Cancer: A Population-Based Analysis.
    Jia H; Li Q; Yuan J; Sun X; Wu Z
    Oncologist; 2020 Apr; 25(4):e644-e650. PubMed ID: 31943509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of second primary malignancies and survival of adult patients with polycythemia vera: A United States population-based retrospective study.
    Khanal N; Giri S; Upadhyay S; Shostrom VK; Pathak R; Bhatt VR
    Leuk Lymphoma; 2016; 57(1):129-33. PubMed ID: 26159045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk and outcomes for second primary human papillomavirus-related and -unrelated head and neck malignancy.
    Adjei Boakye E; Buchanan P; Hinyard L; Stamatakis K; Osazuwa-Peters N; Simpson MC; Schootman M; Piccirillo JF
    Laryngoscope; 2019 Aug; 129(8):1828-1835. PubMed ID: 30582167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.